If the cells you would like to access are currently listed as unavailable or you are ordering from outside of Europe please get in touch via Contact@EBiSC.org.

DRICUi013-A

SC45A10021A

iPSC line

Stock not immediately available - enquire for details
Timepoint: Confluency
Magnification: 4x
Timepoint: Confluency
Magnification: 10x
A CLIP contains information about a cell line including any specific third party obligations relating to, for example, licensing obligations or the donor consent which affect the use of the cell line.

The EBiSC Access and Use Agreement must be completed along with an individual Cell Line Information Pack for each line. Complete the EAUA and send to Contact@EBiSC.org for countersignature. The EAUA must be fully signed before proceeding with your order.
A batch specific Certificate of Analysis will be available to download once you receive your EBiSC iPSC line.

General#

Cell Line

hPSCreg name DRICUi013-A
Alternative name(s)
SC45A10021A
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
UKBi011-A-1
(iLB-AD + ApoE KO)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
UKBi011-A-3
(ApoE 3/3)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
UKBi011-A-4
(ApoE 3/4)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
STBCi006-A-1
(ApoE KO)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
STBCi009-A
(SFC801-03-01)
Donor's gene variants:
PSEN1
Donor diseases:
Alzheimer disease
STBCi010-A
(SFC802-03-06)
Donor's gene variants:
PSEN1
Donor diseases:
Alzheimer disease
STBCi015-B
(SFC809-03-03)
Donor's gene variants:
APP
Donor diseases:
Alzheimer disease
STBCi015-C
(SFC809-03-04)
Donor's gene variants:
APP
Donor diseases:
Alzheimer disease
STBCi065-A
(SFC853-03-03)
Donor diseases:
Alzheimer disease
STBCi013-A
(SFC807-03-01)
Donor's gene variants:
PSEN1
Donor diseases:
Alzheimer disease
STBCi014-A
(SFC808-03-03)
Donor's gene variants:
PSEN1
Donor diseases:
Alzheimer disease
STBCi061-A
(SFC850-03-01)
Donor's gene variants:
MAPT
Donor diseases:
Alzheimer disease
STBCi062-A
(SFC851-03-04)
Donor's gene variants:
MAPT
Donor diseases:
Alzheimer disease
STBCi006-A
(SFC140-04-01)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
UKBi011-A-2
(ApoE 2/2)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
DRICUi011-A
(BS38A10002A)
Donor diseases:
late-onset Alzheimer's disease
DRICUi006-A
(ADANG10496CA)
Donor diseases:
late-onset Alzheimer's disease
DRICUi007-A
(ADANG10605CA)
Donor diseases:
late-onset Alzheimer's disease
DRICUi010-A
(BS38A10004A)
Donor diseases:
late-onset Alzheimer's disease
DRICUi012-A
(NT18A10014A)
Donor diseases:
late-onset Alzheimer's disease
DRICUi004-A
(LC56A10012A)
Donor diseases:
late-onset Alzheimer's disease
DRICUi005-A
(LW44A10001A)
Donor diseases:
late-onset Alzheimer's disease
UKBi011-A
(iLB-AD-169bm-s24)
Donor's gene variants:
APOE, APOE
Donor diseases:
Alzheimer disease
STBCi071-C
(SFC057-07-02)
Donor diseases:
Alzheimer disease
STBCi097-A
(SFC055-04-02)
Donor diseases:
Alzheimer disease
STBCi097-B
(SFC055-04-01)
Donor diseases:
Alzheimer disease
STBCi097-C
(SFC055-04-03)
Donor diseases:
Alzheimer disease
STBCi099-A
(SFC059-03-01)
Donor diseases:
Alzheimer disease
STBCi009-B
(SFC801-03-02)
Donor's gene variants:
PSEN1
Donor diseases:
Alzheimer disease
STBCi009-C
(SFC801-03-03)
Donor's gene variants:
PSEN1
Donor diseases:
Alzheimer disease
STBCi254-A
(SFC143-03-08)
Donor diseases:
Alzheimer disease
STBCi015-A
(SFC809-03-01)
Donor's gene variants:
APP
Donor diseases:
Alzheimer disease
STBCi269-A
(BPC943-03-03)
Donor diseases:
Alzheimer disease
STBCi270-A
(BPC944-03-04)
Donor diseases:
Alzheimer disease
STBCi271-A
(BPC936-03-07)
Donor diseases:
Alzheimer disease
STBCi272-A
(BPC930-03-08)
Donor diseases:
Alzheimer disease
STBCi273-A
(BPC928-03-07)
Donor diseases:
Alzheimer disease
STBCi274-A
(BPC935-03-05)
Donor diseases:
Alzheimer disease
STBCi276-A
(BPC933-03-12)
Donor diseases:
Alzheimer disease
STBCi277-A
(BPC934-03-02)
Donor diseases:
Alzheimer disease
STBCi286-A
(BPC929-03-07)
Donor diseases:
Alzheimer disease
STBCi287-A
(BPC946-04-10)
Donor diseases:
Alzheimer disease
STBCi312-A
(BPC333-03-09)
Donor diseases:
Alzheimer disease
STBCi313-A
(BPC334-03-06)
Donor diseases:
Alzheimer disease
STBCi315-A
(BPC336-03-03)
Donor diseases:
Alzheimer disease
STBCi047-A
(SFC043-03-01)
Donor diseases:
Alzheimer disease
STBCi051-A
(SFC056-04-03)
Donor diseases:
Alzheimer disease
STBCi047-B
(SFC043-03-13)
Donor diseases:
Alzheimer disease
STBCi051-B
(SFC056-04-01)
Donor diseases:
Alzheimer disease
STBCi051-C
(SFC056-04-02)
Donor diseases:
Alzheimer disease
Notes Further anonymized information about the donor including demographic and clinical data will be made available on the Dementia Platforms UK data portal: https://portal.dementiasplatform.uk/

Provider

Depositor UK Dementia Research Institute, Cardiff University (DRICU)
Owner UK Dementia Research Institute, Cardiff University (DRICU)
Distributors
EBiSC
Derivation country United Kingdom

External Databases

hPSCreg DRICUi013-A
BioSamples SAMEA11603441
Cellosaurus CVCL_C1PJ
Wikidata Q114311329

General Information

This EBiSC line can be used for:
Yes
Research use: allowed
Clinical use: no
Commercial use: no

Donor Information#

General Donor Information

Sex male
Age of donor (at collection) 75-79
Ethnicity Caucasian

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Alzheimer Senile Dementia
  • late-onset Alzheimer's
  • Alzheimer Type Senile Dementia
  • Senile Dementia, Alzheimer Type
show more synonyms

Karyotyping (Donor)

Has the donor karyotype been analysed?
Yes
Normal
Karyotyping method: Molecular karyotyping by SNP array
http://

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
Yes

External Databases (Donor)

BioSamples SAMEA11603442

hIPSC Derivation#

General

Source cell type
A thymocyte-derived lymphocyte of immunological importance that is long-lived (months to years) and is responsible for cell-mediated immunity. T lymphocyte cells form rosettes with sheep erythrocytes and, in the presence of transforming agents (mitogens), differentiate and divide. These cells have the characteristic T3 surface marker and may be further divided into subsets according to function, such as helper, cytotoxic, etc.
Synonyms
  • T Cells
  • T Cell
  • T-Lymphocytes
  • Thymus-Dependent Lymphocytes
  • T cell
  • T-Lymphocyte
  • T-Cell
  • T lymphocyte
  • Thymus Derived Lymphocyte
  • T-Cells
show more synonyms
Source cell origin
A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.
Synonyms
  • Reticuloendothelial System, Blood
  • Peripheral Blood
  • peripheral blood
  • blood
  • Blood
  • Whole Blood
  • BLOOD
  • portion of blood
  • vertebrate blood
show more synonyms
Age of donor (at collection) 75-79

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
No
Methods used
PCR
Notes on reprogramming vector detection virus undetectable at passage 11
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions#

Latest released batch

Culture medium Advanced DMEM_F12 + GlutaMAX, Heparin, Ascorbic Acid-2-phosphate magnesium salt, HEPES, FGF-2 basic 145aa, TGF-beta
Passage method EDTA
Surface coating Matrigel
O2 concentration 21
CO2 concentration 5
Temperature 37 °C
The following are the depositor culture conditions, they do not refer to any specific batch.
Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 18 %
CO2 Concentration 5 %
Medium Other medium:
Base medium: Advanced DMEM/F12 (Gibco Thermo Fisher 12634010)
Main protein source: Albumine
Serum concentration: 0 %
Supplements
GlutaMAX (Gibco Thermo Fisher 35050061) 1 %
Heparin (Stem Cell Technologies 07980) 0.1 µg/ml
Ascorbic Acid-2-phosphate magnesium salt (Sigma A8960) 0.22 mM
HEPES 1M pH 7.4 (Gibco Thermo Fisher 15630080) 15 mM
FGF-2 basic 145aa (Miltenyi Biotech 130-093-842) 100 ng/ml
TGF-beta (Biolegend 781804) 2 ng/ml
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation#

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
TRA 1-60
Yes
NANOG
Yes
Morphology pictures
IPMAR_DRICUi013-A_Morphology .pdf
IPMAR_DRICUi013-A_Morphology
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Marker Expressed
C-X-C Chemokine Receptor Type 4
Yes
SRY-box transcription factor 17
Yes
Morphology
IPMAR_DRICUi013-A_Endoderm.pdf
IPMAR_DRICUi013-A_Endoderm_ICC image
Mesoderm
Ont Id: UBERON_0000926
Marker Expressed
C-X-C Chemokine Receptor Type 4
Yes
BRACHYURY
Yes
Morphology
IPMAR_DRICUi013-A_Mesoderm.pdf
IPMAR_DRICUi013-A_Mesoderm_ICC image
Ectoderm
Ont Id: UBERON_0000924
Marker Expressed
Paired box 6
Yes
orthodenticle homeobox 2
Yes
Morphology
IPMAR_DRICUi013-A_Ectoderm.pdf
IPMAR_DRICUi013-A_Ectoderm_ICC image

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping#

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
No gross abnormalities
Passage number: 14
Karyotyping method: Molecular karyotyping by SNP array
http://

Other Genotyping (Cell Line)